Analyst consensus rating
CervoMed Analyst Rating: Strong Buy
Direct answer
CervoMed's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $15.00.
Forecast evidence checked October 27, 2026.
Get free CervoMed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.22
- Average price target
- $15.00
- High price target
- $25.00
- Low price target
- $7.00
- Low target gap
- +215.3%
- Target upside
- +575.7%
- High target gap
- +1,026.1%
- Target range width
- 810.8%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for CervoMed?
CervoMed has a verified Strong Buy consensus. The same dataset has an average price target of $15.00.
How far are CervoMed's low and high targets from the recorded price?
The low target implies +215.3%, while the high target implies +1,026.1%.
How many analysts are included in CervoMed's consensus?
The verified consensus includes 5 analysts.
How is CervoMed's target upside or downside calculated?
The average target of $15.00 is divided by the recorded price of $2.22, then one is subtracted to produce +575.7%. This does not guarantee a future return.
When was CervoMed's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.